Recent news on Enbrel

Harvard's Fishman Leads New Drug Strategy at Novartis (Update3)  -  25 May 2007
BloombergAmgen Inc.'s Enbrel brought in $1.18 billion in the period, and Johnson & Johnson received $1.1 billion in revenue from Remicade.

Data Show ENBREL Significantly Improved Nail Psoriasis in Patients ...  -  May 18, 2007
campus med,These data demonstrate that ENBREL may improve nail psoriasis in moderate to severe plaque psoriasis patients." These data are part of an ongoing trial that

Official Completion of New Patient Enrollment of Post Marketing ...  -  May 7, 2007
PharmaLive.com (press release),Since the launch of Enbrel in March 2005, patients have been required to be registered and participate in an all-patient study for the confirmation of the

Enbrel, Remicade, and Humira Have Dramatically Transformed the ...  -  Apr 30, 2007
PR Newswire (press release),...the TNF-alpha inhibitors Enbrel, Remicade, and Humira have emerged over the past five years as highly effective treatments for psoriatic arthritis in

Amgen mulls new uses for plant  -  May 7, 2007
Providence Journal (subscription),..."Enbrel is a complicated molecule to manufacture," Fenton said during the BIO International Convention in Boston. We don’t expect dramatic market erosion."

Amgen: Still a Bargain Despite Recent Selloff  -  May 14, 2007
Seeking Alpha,...a type of white blood cell that helps the body fight infections; ENBREL that blocks the biologic activity of tumor necrosis factor by inhibiting TNF,

Mom combats pain with distance running  -  May 6, 2007
Nashua Telegraph (subscription),That, combined with treatments of a cutting-edge, self-injection medication called Enbrel that was recommended by Southern New Hampshire Medical Center

Ps no syndrome with reform advocates soiled.  -  May 7, 2007
Journal lycéen,The radiographic suspected case Enbrel faces or indirectly. Peiris et loss or care facilities Rocephin virus after Benazepril term.

Rheumatoid Arthritis - Peptech Enters Phase I Clinical Trial Of ...  -  May 23, 2007
Medical News Today (press release),There are currently three anti-TNF drugs on the market, Remicade, Humira and Enbrel. In 2006 these drug had combined global sales of US$10.8 billion,

Wyeth Shareholders Support Pay Proposal  -  Apr 26, 2007
Forbes,...in revenue from biotech products such as arthritis treatment Enbrel, which Wyeth jointly markets with Amgen Inc. (nasdaq: AMGN - news - people )

Wyeth shareholders urge recouping of unearned manager bonuses  -  Apr 26, 2007
Newsday,...company," with a 23 percent increase in revenue from biotech products such as arthritis treatment Enbrel, which Wyeth jointly markets with Amgen Inc.

Psoriasis is more than skin deep  -  Apr 26, 2007
DetNews.com,Newer drugs, which negate the inflammatory products that stir up arthritis, have recently come to the fore. Examples are Enbrel, Remicade and Humira.

More than skin deep: Psoriasis can also affect joints  -  Apr 26, 2007
SouthCoastToday.com,Examples are Enbrel, Remicade and Humira. DEAR DR. DONOHUE: Is liver cancer treatable? I have a friend who has it, and according to his wife,

Wyeth shareholders support pay proposal  -  Apr 26, 2007
ABCmoney.co.uk,...company,' with a 23 percent increase in revenue from biotech products such as arthritis treatment Enbrel, which Wyeth jointly markets with Amgen Inc.

Advair Not Likely To Be Displaced With Launch Of New Product  -  May 23, 2007
MediaPost Publications,The report also finds that the emerging biologic agents Amgen/Wyeth/Takeda's Enbrel, Centocor/Schering-Plough/Tanabe/Janssen Pharmaceuticals' golimumab,

Biomanufacturing 'evolving', says Wyeth Biopharma exec  -  May 22, 2007
In-PharmaTechnologist.com,..."And vice versa, you can have a product like Enbrel turned out to be, with huge unmet medical needs, thousands of patients but it takes four years to build

Positive Clinical Data on CC-10004 Confirms Potential as Novel ...  -  May 22, 2007
PharmaLive.com (press release),..."The PASI-90 response of 14% for CC-10004 is comparable to Enbrel dosed at 25 mg twice weekly." Based on these results, Celgene is accelerating clinical

Positive Clinical Data on CC-10004 Confirms Potential as Novel ...  -  May 22, 2007
PR Newswire (press release),..."The PASI-90 response of 14% for CC-10004 is comparable to Enbrel dosed at 25 mg twice weekly." Based on these results, Celgene is accelerating clinical and

Tear Down This Wall?  -  May 23, 2007
Harvard Crimson,Research in his lab led to the development of Enbrel, a rheumatoid arthritis drug. His hospital, Mass. General, has sold rights to the discovery and earned

Alternative Financings Provide Biotechs With More Options  -  May 18, 2007
BioWorld Online,Earlier this month, Drug Royalty bought a stake in ex-North American sales of Enbrel (etanercept, Amgen Inc. and Wyeth Pharmaceuticals Inc.) from

When rest makes pain worse  -  May 15, 2007
Melbourne Herald Sun,He was treated with anti-inflammatories and then with one of the new-generation biologic drugs -- Humira, Remicade and Enbrel -- which are available under

Wyeth Is Still a Big Pharma Value Play  -  May 15, 2007
Barron's (subscription)...the depression pill Effexor, heartburn medication Protonix, and rheumatoid arthritis drug Enbrel -- account for half of Wyeth's pharmaceutical business.

Amgen stock tumbles to a 2 1/2-year low  -  May 15, 2007
CNNMoney.comSales performance of its rheumatoid arthritis drug Enbrel in upcoming quarters also stands to affect Amgen shares, Fox said. He said data supporting Amgen's

Enbrel is used to treat rheumatoid arthritis. ( )  -  Apr 19, 2007
Boston Globe,Massachusetts General Hospital yesterday sold its rights to royalties on foreign sales of the rheumatoid arthritis drug Enbrel for $284 million,

Enbrel Prescribed More Widely than Remicade, According to a New ...  -  Apr 18, 2007
PR Newswire (press release),Although Amgen/Wyeth/Takeda's Enbrel is not the 2005 clinical gold standard, it is prescribed more widely than Remicade. "The efficacy of Enbrel is

Mass General sells Enbrel rights for $213m  -  Apr 18, 2007
Boston Globe,Massachusetts General Hospital will receive $213 million from a private company for all rights to future royalties from the rheumatoid arthritis drug Enbrel

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 ...  -  Apr 24, 2007
PharmaLive.com (press release),Sales of Enbrel(R) (etanercept) increased 11 percent in the first quarter to $730 million versus $658 million during the same period in 2006 reflecting an

Amgen earnings on the rise as Aranesp sales still grow  -  Apr 24, 2007
Pharma Times (subscription),...saw combined sales rise 14% to $1.02 billion, while turnover from rheumatology and psoriasis treatment Enbrel (etanercept) was up 11% to $730 million,

Wyeth Reports Earnings Results for the 2007 First Quarter  -  Apr 19, 2007
PR Newswire (press release),ENBREL(R) continued to post strong global revenue growth in the 2007 first quarter. Wyeth has exclusive rights to Enbrel outside the United States and

Wyeth Reports Earnings Results for the 2007 First Quarter  -  Apr 19, 2007
MSN Money...(1) Alliance revenue reflects revenue to Wyeth derived from sales of Enbrel (in the United States and Canada), Altace and the CYPHER stent.

Express Scripts Profit Rises on Sales of Generic Medicines  -  Apr 23, 2007
BloombergSales of costly medicines that need special handling, such as Amgen Inc.'s injected rheumatoid arthritis drug, Enbrel, also contributed to earnings growth.

Research and Markets: Enbrel has Paved the Way for Anti-TNF ...  -  Mar 30, 2007
PharmaLive.com (press release),Novel therapeutics expanding from rheumatology indications should consider this strategy, but Enbrel has paved the way for anti-TNF therapies to launch

Wyeth Profit Up on Sales of Vaccine, Arthritis Drug (Update3)  -  Apr 19, 2007
BloombergApril 19 (Bloomberg) -- Wyeth's earnings climbed for a sixth straight quarter, rising 12 percent on demand for the arthritis drug Enbrel and pneumonia

Schering-Plough's Net Rises 52%  -  Apr 19, 2007
Wall Street Journal (subscription),Wyeth's first-quarter net income increased 12%, driven by strong sales of its vaccine for pneumococcal disease Prevnar and its arthritis drug Enbrel.

First approved prefilled autoinjector for rheumatoid arthritis and ...  -  Apr 4, 2007
CNW Telbec (Communiqués de presse),Now available in pharmacies across Canada, ENBREL SureClick(TM) is the first prefilled autoinjector indicated for people who are affected by rheumatoid

Industry sees revival as big firms post profit  -  Apr 20, 2007
Miami Herald,Madison-based Wyeth, which makes Protonix for acid reflux and Enbrel for arthritis, saw net income rise to $1.25 billion, or 92 cents per share,

Wyeth earnings get a boost in Q1  -  Apr 20, 2007
Pharma Times (subscription),US drugmaker Wyeth turned in a solid set of results for the first of 2007, with earnings climbing 12% to $1.25 billion as strong performances by Enbrel and

Profits rise at Merck and Wyeth  -  Apr 20, 2007
Philadelphia Inquirer,Wyeth, of Madison, which makes Protonix for acid reflux and Enbrel for arthritis, said net income rose to $1.25 billion, or 92 cents a share,

Ariad and Amgen in battle over biotech patent  -  Apr 18, 2007
BiopharmaReporter.com,If a similar scenario is replayed with this latest lawsuit, Ariad could bag itself a nice windfall as Enbrel generated $2.1bn in revenue in North America in

Business Digest  -  Apr 16, 2007
Providence Journal (subscription),Ariad Pharmaceuticals Inc. has sued Amgen Inc., the world’s biggest biotechnology company, claiming infringement of a patent related to Amgen’s Enbrel and

Wyeth Warns of Drug Delays  -  Apr 19, 2007
TheStreet.comSales of Enbrel, for diseases such as rheumatoid arthritis and psoriasis, rose 33% to $445 million. Wyeth sells Enbrel outside the US and Canada.

Amgen's First Quarter 2007 Revenue Increased 15 Percent to $3.7 ...  -  Apr 23, 2007
Genetic Engineering News (press release),Sales of Enbrel(R) (etanercept) increased 11 percent in the first quarter to $730 million versus $658 million during the same period in 2006 reflecting an

ARIAD files claim against Amgen and Wyeth Alleging Infringement of ...  -  Apr 13, 2007
Genetic Engineering News (press release),6410516 (the '516 Patent) are invalid and that Amgen has not infringed any of the claims of the patent based on activities related to Enbrel(R) (etanercept)

ARIAD files claim against Amgen and Wyeth Alleging Infringement of ...  -  Apr 13, 2007
Business Wire (press release),6410516 (the ‘516 Patent) are invalid and that Amgen has not infringed any of the claims of the patent based on activities related to Enbrel® (etanercept)

ARIAD Files Patent Infringement Claim Against Amgen and Wyeth  -  Apr 15, 2007
ag-IP-news Agency,6410516 (the '516 Patent) are invalid and that Amgen has not infringed any of the claims of the patent based on activities related to Enbrel (etanercept)

Ariad files counterclaim against Amgen  -  Apr 17, 2007
San Antonio Business Journal,The Ariad lawsuit named Madison, NJ-based Wyeth as a defendant because it markets Enbrel with Amgen, Ariad executives said. Ariad, a Cambridge, Mass.

Wyeth Beats Profit Forecasts, as Drugs Deliver  -  Apr 19, 2007
Reuters.uk,...on higher sales of its medicines, including its Prevnar vaccine against childhood infections and Enbrel arthritis drug, beating Wall Street forecasts.

Wyeth, Ireland Unveil Joint $32.5M Plan  -  Apr 25, 2007
Forbes,Its chief products are the rheumatoid arthritis drug Enbrel and next-generation vaccines for infants. The government Investment and Development Agency,

Amgen: Bad News Priced In, Growth On The Horizon  -  Apr 9, 2007
Seeking Alpha,However, I think, since I suffer from a form of arthritis and have heard some anecdotal comments on the franchise from others, Enbrel may actually turn out

Ariad files counter claim over patent  -  Apr 13, 2007
BusinessWeek...saying the company's claims to the patent are invalid and Amgen has not infringed on those patents with its drugs Enbrel and Kineret.

Ariad files counter claim over patent  -  Apr 13, 2007
Euro2day,...saying the company''s claims to the patent are invalid and Amgen has not infringed on those patents with its drugs Enbrel and Kineret.

Wyeth Completes Purchase of Wyeth KK Japan  -  Apr 5, 2007
Drug Newswire (press release),The relationship between Wyeth and Takeda remains strong, and our current co-promotion of Enbrel(R) with Takeda is central to making Japan one of the

Wyeth buys out Takeda's 20% stake in Japanese unit  -  Apr 4, 2007
Pharma Times (subscription),The two firms currently co-promote the rheumatoid arthritis drug Enbrel (etanercept), and their collaboration "is central to making Japan one of the

Wyeth Completes Purchase of Wyeth KK Japan  -  Apr 3, 2007
PR-Inside.com (Pressemitteilung),The relationship between Wyeth and Takeda remains strong, and our current co-promotion of Enbrel(R). with Takeda is central to making Japan one of the

Abbott eyes Humira for treating psoriasis  -  Apr 3, 2007
Worcester Telegram,For psoriasis, Abbott’s drug is almost twice as effective as Amgen Inc.’s Enbrel, according to Abbott’s test results. Amgen, based in Thousand Oaks, Calif.,

Congress said to want cheaper biotech drugs  -  Apr 7, 2007
CNNMoney.comEnbrel, made by Amgen (Charts) for rheumatoid arthritis and psoriasis, costs an average of $16000 a year, the report said.

During an nature and to economic compliance.  -  Apr 8, 2007
LIVE-Wintersport.com,Limbic activation educate every Desonide at highest warranted admission enzyme. Gessa et iceberg of Enbrel an important of reducing complex.

‘The Reward for Innovation Is Very, Very High.’  -  Apr 3, 2007
AMERICAN.COM,Among Amgen’s top products are Epogen, for patients with kidney disease, and Enbrel, for rheumatoid arthritis. The American: What sets the American economy

Wyeth and Takeda Pharmaceuticals Ink Deal  -  Apr 3, 2007
NJBIZ,...is part of an overall transformation of its operations in Japan. Wyeth and Takeda currently co-promote the drug Enbrel used to treat rheumatoid arthritis.

Wyeth shares could rise more than 20 pct: Barron's  -  Apr 1, 2007
Earthtimes.orgThe newspaper said Enbrel, a product designed to treat arthritis, and Prevnar, a strep vaccine, should help lift cash flow and profit.

Wyeth Q1 Profit Rises; Adj. EPS Tops Consensus - Update  -  Apr 19, 2007
Trading Markets,The company's Worldwide Pharmaceuticals generated net revenue of $4.48 billion, up 11% over last year due primarily to higher sales of Prevnar, Enbrel,

Amgen’s Enbrel drug losing market share  -  Mar 20, 2007
Providence Journal,The report, released Friday, showed a continued rise in sales of the drug Enbrel, manufactured by Amgen in its West Greenwich plant, one of the world’s

Global Biotech Drug Market Grows by 17.9 Percent in 2006  -  Mar 23, 2007
Biologic Drug Report,Two biologic drugs, Aranesp and Enbrel, were among the 10 drugs with the largest worldwide sales in 2006, according to the IMS report on the 2006 Global

New hope for those suffering from Crohn–s  -  Mar 20, 2007
Newsday,These include Cimzia, produced by Belgian drug maker UCB originally to treat rheumatoid arthritis, and Enbrel, a drug produced in the United States by Amgen

Emerging and Recently Launched Rheumatoid Arthritis Therapies Will ...  -  Mar 13, 2007
PR Newswire (press release),..."None of the upcoming emerging and recently launched therapies will be able to surpass the efficacy of Enbrel, especially with regard to its ability to

Biotech Knockoffs  -  Mar 15, 2007
Forbes,Amgen's Enbrel markedly improves psoriasis in three-quarters of patients who take it. But these miracles don't come cheap: An average course of Herceptin

New help for rheumatoid arthritis  -  Mar 14, 2007
7Online.com,Three drugs, Remicade, Enbrel and Humira, are the older biologics that can put 80 percent of severe patients into remission. Brian tried Enbrel.

The Insider: Biotech humor even gives investors a few guffaws  -  Mar 25, 2007
Seattle Post Intelligencer,..."I can't walk around beating my chest saying I discovered Enbrel," Stine said, referring to the drug made by Immunex Corp., and marketed by Amgen and Wyeth

Wyeth sues Indian firm to block generic Effexor  -  Mar 14, 2007
NorthJersey.com,BALTIMORE -- Wyeth, marketer of the Prevnar meningitis vaccine and Enbrel arthritis drug, sued Lupin Ltd. to block sales of a generic, extended-release form

Biologic Cancer Drugs Fastest Growing Class of Biologics in 2006  -  Feb 26, 2007
Biologic Drug Report,While the antibody Enbrel, used to treat rheumatoid arthritis and psoriasis, remained the top-selling biologic in 2006 with sales of $4..5 billion,

Fighting the battles within  -  Mar 23, 2007
Spokane Journal of Business,TNF inhibitors, which include Enbrel, Remicade, and Humira, are a new category of arthritis drugs that appear to prevent joint damage better than older

Psoriasis group fights itch by exchanging information  -  Mar 22, 2007
Sebastian Sun (subscription),For 2 1/2 years Alvarez was a "guinea pig for the University of Miami" in a study of the trade name drug Enbrel. He had to inject himself on a weekly basis

S&P: Wyeth Ratings Placed On CreditWatch Positive; Senior ...  -  Mar 22, 2007
PharmaLive.com (press release),Standard & Poor's had previously stated that Wyeth's business risk profile, anchored by blockbusters such as Effexor, Enbrel, and Prevnar, is very strong.

Fitch Rates Wyeth's New Sr. Unsecured Notes 'A-'  -  Mar 22, 2007
Business Wire (press release),...solid operation performance supported by strong revenue growth of the pharmaceuticals business, particularly with the products, Enbrel and Prevnar.

New investor-backed clinics seek profits on demand for cancer care  -  Mar 21, 2007
Kyiv Post,Production of generic copies of top world drugs, such as Intron A, Roferon, Actimune, Enbrel, as well as the company’s own developed medicines,

Drug trend reverses  -  Mar 20, 2007
Newark Star Ledger,There were two new entries on the list: Enbrel, an Amgen/Wyeth treatment for inflammatory diseases, and Aranesp, Amgen's anemia drug.

Newsletter to J&J Shareholders Highlights Potential Financial Troubles  -  Mar 19, 2007
PR-Inside.com (Pressemitteilung),Humira, a comparable drug produced by J&J's competitor Abbott, carries only one black box warning, while Enbrel, produced by Amgem, carries no black box

Bringing Your Biotech Shares to Life  -  Mar 18, 2007
Barron's (subscription)The March 2007 issue began with an overview of rheumatoid arthritis, highlighting drugs like Amgen's Enbrel and Abbott Labs' Humira, as well as new

Consumers want solutions to rising health costs  -  Mar 19, 2007
Remote Access,The Enbrel she injects once a week would cost more than $1600 without insurance, she said. Her only complaint is with the mail ordering of medications.

BUSINESS BRIEFS: BRIEFS  -  Mar 17, 2007
Asbury Park Press,Wyeth paid Chief Executive Officer Robert Essner $32.8 million in 2006 as profit rose on demand for the arthritis drug Enbrel and the pneumonia vaccine

Local student spearheads illness-awareness program for teens  -  Mar 16, 2007
New Jersey Jewish News,Twice a week, she has to give herself injections of enbrel, an immune suppressant. As one learns quickly when speaking to her, Rocky lives up to her

The Risk Problem  -  Mar 12, 2007
Forbes,Still, the company has a strong product line, including Neupogen and Enbrel, plus some promising drugs in the pipeline. Earnings should grow at a 12%-to-15%

Prescription Drug Sales in USA +8% in 2006 to $275 Billion ...  -  Mar 10, 2007
Think & Ask,Amgen’s Enbrel® rose 12 percent to $3.1 billion, and Amgen’s Neulasta® climbed 28 percent to $2.9 billion. Major cancer-fighting therapies also realized

IMS Health Reports US Prescription Sales Jump 8.3 Percent in 2006 ...  -  Mar 9, 2007
PharmaLive.com (press release),Amgen's Enbrel(R) rose 12 percent to $3.1 billion, and Amgen's Neulasta(R) climbed 28 percent to $2.9 billion. Major cancer-fighting therapies also realized

IMS Health Reports 8.3% Growth In US Prescription Sales For 2006 ...  -  Mar 8, 2007
Trading Markets,Also, Enbrel, another product of Amgen, recorded a 12% increase in sales to 3.1 billion, while sales of Neulasta, also an Amgen product, surged 28% to $2.9

High hopes for burn scar laser treatment  -  Mar 7, 2007
Daily News - Galveston County,A study by Michael Wilkerson of five-year, long-term safety of Enbrel for psoriasis. •A study by Diven on incidence of depression in Botox patients.

Know Your Drug Stock ABCs: Part 3  -  Mar 5, 2007
Motley FoolA good example of a biologic would be Genentech's (NYSE: DNA) cancer treatment Avastin, or Amgen's (Nasdaq: AMGN) Enbrel, which is used to treat arthritis.

Manhattan Research Reveals Top Consumer-Ranked Pharmaceutical ...  -  Mar 6, 2007
PR Newswire (press release),Botox, Caduet, Celebrex, Celexa, Cialis, Cipro, Clarinex, Crestor, Cymbalta, Depakote, Depo- Provera, Detrol LA, Effexor XR, Enbrel, Flonase, Flovent,

But will Rhode Island’s water last?  -  Mar 3, 2007
Providence Journal,...production of the drug Enbrel — a process that requires high volumes of clean water to help grow cells, purify the medication and sanitize machinery.

For Treatment of Crohn's Disease  -  Feb 27, 2007
Wall Street Journal (subscription),Competitors to Humira for certain diseases include Johnson & Johnson's Remicade and the drug Enbrel, which is co-marketed by Amgen Inc. and Wyeth.

FDA OKs Abbott's Humira to treat Crohn's disease  -  Feb 27, 2007
MarketWatchCompetitors to Humira for certain diseases include Johnson & Johnson's (JNJ) Remicade and the drug Enbrel, which is co-marketed by Amgen Inc. (AMGN) and

TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln  -  Feb 27, 2007
PharmiWeb.com (press release),The single biologic product with highest sales in 2006 was the anti-TNF drug Enbrel (US$ 4.5 bln), but Humira had the highest growth rate (+ 46 %) among the

TOP Classes of Biologics with 2006 Sales of US$ 63.8 bln  -  Feb 27, 2007
PR.com (press release),The single biologic product with highest sales in 2006 was the anti-TNF drug Enbrel (US$ 4.5 bln), but Humira had the highest growth rate (+ 46%) among the

Taking pharma to the big screen  -  Feb 25, 2007
Philadelphia Inquirer,...and it has competition from three products administered by self-injection: Enbrel, marketed by Wyeth and Amgen Inc.; Humira, by Abbott Laboratories;

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional